Financial Year |
March 31 2023 |
Monetary Funds |
158,584,431.96 |
Held-for-trading Financial Assets |
174,683,670.91 |
Notes Receivable |
100,416,957.64 |
Accounts Receivable |
417,592,370.28 |
Advances to Suppliers |
31,246,893.21 |
Other Receivables |
3,205,354.01 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
154,520,479.03 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
38,735,815.91 |
Total Current Assets |
1,240,411,003.18 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
5,886,792.55 |
Fixed Assetes |
547,014,568.28 |
Under-construction Projects |
121,274,397.88 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
32,049,497.02 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
19,598,774.80 |
Deferred Income Tax Assets |
24,326,297.21 |
Other Non-Current Assets |
133,572,236.22 |
Sub-Total of Non-Current Assets |
1,047,901,414.49 |
Total Assets |
2,288,312,417.67 |
Short-Term Loans |
85,975,775.09 |
Trading Financial liabilities |
-- |
Notes Payable |
27,005,267.00 |
Accounts Payable |
106,030,106.71 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
36,372,713.90 |
Taxes Payable |
41,515,642.82 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
944,383.39 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
20,000,000.00 |
Other Current Liabilities |
4,684,013.87 |
Sub-Total of Current Liabilities |
323,211,301.00 |
Long-term Loans |
95,679,857.78 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
5,503,775.74 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
267,519,503.28 |
Total Liabilities |
590,730,804.28 |
Paid-In Capital(Or Share Stock) |
109,886,026.00 |
Capital Surplus |
861,897,201.61 |
Surplus Reserve |
48,609,829.95 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
677,188,555.83 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,697,581,613.39 |
Owner's Equity(Stockholder's Equity) |
1,697,581,613.39 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,288,312,417.67 |